Showing 81–100 of 631 signals
Company disclosure·globenewswire.com·Aug 18, 2026·Commercial·Low materiality
CompaniesLiminatus Pharma, Inc.
2 sources — primary and 1 also reporting
Company disclosure·globenewswire.com·Aug 18, 2026·Commercial·Low materiality
CompaniesIridex Corporation
2 sources — primary and 1 also reporting
Company disclosure·globenewswire.com·Aug 18, 2026·Approval·High materiality
CompaniesSilo PharmaAssetsSPC-15Diseasespost-traumatic stress disorder (PTSD)
2 sources — primary and 1 also reporting
Company disclosure·globenewswire.com·Aug 18, 2026·Other·Low materiality
CompaniesZenas BioPharma
3 sources — primary and 2 also reporting
Company disclosure·globenewswire.com·Aug 18, 2026·Commercial·High materiality
CompaniesFlyteFullPAC
Company disclosure·globenewswire.com·Aug 18, 2026·Commercial·High materiality
CompaniesImmunocine Cancer Center
2 sources — primary and 1 also reporting
Company disclosure·globenewswire.com·Aug 18, 2026·Other·Low materiality
CompaniesGeron Corporation
2 sources — primary and 1 also reporting
Company disclosure·globenewswire.com·Aug 18, 2026·M&A·Low materiality
CompaniesLakefront Biotherapeutics
Company disclosure·globenewswire.com·Aug 18, 2026·Other·Low materiality
CompaniesEikon TherapeuticsCantor FitzgeraldUniversity of Texas MD Anderson Cancer CenterDiseasesbreast cancerovarian cancerprostate cancerpancreatic cancer
2 sources — primary and 1 also reporting
Company disclosure·globenewswire.com·Aug 18, 2026·Commercial·High materiality
CompaniesPsyence BioMedPsyLabsAssetsibogaine
Trade press·koreabiomed.com·Aug 19, 2026·Other·High materiality
CompaniesSanofiAssetsAltuviiioDiseasesHemophilia A
Regulator·fda.gov·Aug 18, 2026·Discontinuation·Low materiality
CompaniesDreyer's Grand Ice Cream, Inc.
Regulator·fda.gov·Aug 18, 2026·Other·Low materiality
Diseasesnonhealing chronic wounds
Regulator·fda.gov·Aug 18, 2026·Other·Low materiality
Regulator·fda.gov·Aug 18, 2026·Other·Low materiality
Regulator·fda.gov·Aug 18, 2026·Other·Low materiality
Regulator·fda.gov·Aug 18, 2026·Other·Low materiality
Diseasesopioid use disorder
Regulator·fda.gov·Aug 18, 2026·Commercial·Low materiality
CompaniesBecton DickinsonHuons Co.Assetssodium chloride ampules
Trade press·koreabiomed.com·Aug 19, 2026·Other·Low materiality
Trade press·koreabiomed.com·Aug 19, 2026·Other·High materiality
Diseasesskin diseaseskin diseases